| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -563.9% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 17.3 | n/a |
| Pr/Book | 11.4 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 90.4% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-21 | 0.69 | (1.85) | (1.17)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-22 | 0.05 | (5.63) | 5.44p | 3.2 | n/a | n/a | n/a | 0.0% |
| 30-Jun-23 | 0.06 | (5.98) | (5.44)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-24 | 0.50 | (7.75) | (4.65)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-25 | 0.95 | (5.43) | (0.89)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Director/PDMR Notification | 01-Sep-2026 | 07:00 | RNS |
| Board Appointments | 21-Aug-2026 | 07:00 | RNS |
| ShareSoc Investor Presentation | 13-Aug-2026 | 07:00 | RNS |
| Director dealings: Genedrive CEO raises stake | 01-Sep-2026 | ShareCast |
| Genedrive collects £0.76m R&D tax credit | 05-Jun-2026 | ShareCast |
| Sussex NHS trust moves to routine use of Genedri... | 05-May-2026 | ShareCast |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 28-Aug-26 | Buy | Russell Shaw | 0.14p | 700,000 | £980.00 |
| 28-Aug-26 | Buy | Gino Miele | 1.38p | 700,000 | £9,660.00 |
| Currency | UK Pounds |
| Share Price | 1.38p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 1.40 |
| 52 Week Low | 0.23 |
| Volume | 0 |
| Shares Issued | 1,605.57m |
| Market Cap | £22.08m |
| RiskGrade | 747 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| CFO | Russell Shaw |
| CEO | Gino Miele |
| Chair | Graham Cole CBE |
You are here: research